Clinical Trials Browser

Phase 1 × Recurrence × spartalizumab × Clear all

NCT05631886 2023-08-28

Combination of CAR-DC Vaccine and ICIs in Malignant Tumors

Phase 1 Recruiting

Lymphoma, Neoplasm Metastasis, Recurrence